Homeostatic proliferation of NK cells: friend or foe in cellular immunotherapy?

被引:0
|
作者
Marek, Natalia [1 ]
Trzonkowski, Piotr [1 ]
机构
[1] Univ Gdansk, Dept Clin Immunol & Transplantol Med, PL-80952 Gdansk, Poland
关键词
homeostatic proliferation; long-lived NK cells; long-term innate immunity; NK cells; viral immunity; T-CELLS; CD4(+); NAIVE; PHENOTYPE;
D O I
10.2217/IMT.11.53
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evaluation of: Sun JC, Beilke JN, Bezman NA, Lanier LL: Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J. Exp. Med. 208(2), 357-368 (2011). NK cells are an important tool in cellular immunotherapy owing to their role in infections and antitumor immunity. Until recently, these cells have been thought to be short-lived cytotoxic effectors that are cleared from the body soon after resolution of an immune response. In the commented study, Sun et al. confirmed that, similar to T cells, NK cells sensed the space in the immune system and underwent homeostatic proliferation in order to provide necessary protection to the body. Moreover, homeostatically driven NK cells persisted in the tissues for a long time without loss of activity. These findings have important consequences for immunotherapy, suggesting that the mechanisms of homeostatic expansion can be deployed in order to expand NK cells for therapeutic purposes in vivo. As homeostatically driven NK cells are long-lived effectors, such therapies can exert prolonged effects for the immunity of the patients.
引用
收藏
页码:727 / 729
页数:3
相关论文
共 50 条
  • [31] Persistence of fetal cells in the mother: friend or foe?
    Lissauer, D.
    Piper, K. P.
    Moss, P. A. H.
    Kilby, M. D.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 114 (11) : 1321 - 1325
  • [32] Host Mast Cells in Leishmaniasis: Friend or Foe?
    Naqvi, Nilofer
    Srivastava, Rahul
    Selvapandiyan, Angamuthu
    Puri, Niti
    [J]. TRENDS IN PARASITOLOGY, 2020, 36 (12) : 952 - 956
  • [33] Are Dendritic cells a friend or foe for dilated cardiomyopathy?
    Yang, Jing-Jing
    Tao, Hui
    Li, Jun
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (07) : 828 - 828
  • [34] Glial cells — friend and foe in Huntington disease?
    Heather Wood
    [J]. Nature Reviews Neurology, 2016, 12 (8) : 430 - 431
  • [35] MAIT cells in hidradenitis suppurativa: friend or foe?
    Gallagher, C.
    Cotter, C.
    Kirthi, S.
    Salim, A.
    Connolly, M.
    O'Brien, A.
    Hogan, A.
    Tobin, A. -M.
    [J]. EXPERIMENTAL DERMATOLOGY, 2019, 28 : 10 - 10
  • [36] Regulatory T cells in malaria - friend or foe?
    Finney, Olivia C.
    Riley, Eleanor M.
    Walther, Michael
    [J]. TRENDS IN IMMUNOLOGY, 2010, 31 (02) : 63 - 70
  • [37] B cells in tumor metastasis: friend or foe?
    Xu, Yuqiu
    Mao, Yihao
    Lv, Yang
    Tang, Wentao
    Xu, Jianmin
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (08): : 2382 - 2393
  • [38] Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?
    van Schaik, Thijs A.
    Chen, Kok-Siong
    Shah, Khalid
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] Cellular Immunotherapy Treatment with NK-92-Cells for advanced Tumors
    Ruchalla, Elke
    [J]. TRANSFUSIONSMEDIZIN, 2014, 4 (02) : 67 - +
  • [40] NK cells and Immunotherapy
    Tian, Zhigang
    [J]. SEMINARS IN IMMUNOLOGY, 2017, 31 : 1 - 2